MMJ Wishes DEA Officials a Happy Thanksgiving - While Reminding Them That Huntington's Chorea Doesn't Take Holidays.
WASHINGTON, D.C. / ACCESS Newswire / November 27, 2025 / MMJ International Holdings Extends Warm Thanksgiving Wishes to DEA's Anti-Cannabis Holdouts - And Encourages a Moment of Reflection for Patients Still Waiting for Federally Legal Medicine
MMJ International Holdings, developer of the nation's fully federally compliant, natural cannabis-derived pharmaceutical for Huntington's Disease and Multiple Sclerosis, today extends a sincere Happy Thanksgiving to the small but deeply entrenched group of DEA officials who, for the past seven years, have ensured that American patients still lack access to a medicine federal law actually allows MMJ to develop.
On this national day of gratitude, MMJ respectfully invites the former and current architects of the DEA's anti-cannabis posture - the institutional "old guard" of the Biden-era bureaucracy - to pause between turkey, football, and family and consider the Americans living with crippling neurological disorders who continue to wait for relief.
Copyright
©420 Intel